Vizsgálati helyszín
The West Clinic, PLLC dba West Cancer Center
Germantown, Tennessee 38138, Egyesült ÁllamokMég nincs intézményhez kötve
Az itteni vizsgálatok
Miről szól a helyszín 11 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis6 vizsgálat
- 1. fázis1 vizsgálat
- 1/2. fázis1 vizsgálat
- 2. fázis1 vizsgálat
- 2/3. fázis1 vizsgálat
- Állapot
- Toboroz7 vizsgálat
- Fut, nem toboroz4 vizsgálat
- Fő szponzor
- Pfizer4 vizsgálat
- Gilead Sciences2 vizsgálat
- Bristol-Myers Squibb1 vizsgálat
- Daiichi Sankyo1 vizsgálat
- Eli Lilly and Company1 vizsgálat
- és még 2
Futó vizsgálatok
Toboroz
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
NCT07028853· 3. fázis· Pfizer· Forrás
Toboroz
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
NCT07062965· 3. fázis· Pfizer· Forrás
Toboroz
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
NCT06764771· 1. fázis· Bristol-Myers Squibb· Forrás
Contact: Daniel Vaena, Site 0024
Toboroz
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
NCT06581406· 2/3. fázis· Replimune, Inc.· Forrás
Contact: Arnel M. Pallera, MD
Toboroz
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
NCT06203210· 3. fázis· Daiichi Sankyo· Forrás
Contact: Principal Investigator
Toboroz
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
NCT05768139· 1/2. fázis· Eli Lilly and Company· Forrás
Contact: Gregory Vidal (principal investigator)
Fut, nem toboroz
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
NCT05382286· 3. fázis· Gilead Sciences· Forrás
Fut, nem toboroz
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer
NCT05382299· 3. fázis· Gilead Sciences· Forrás
Fut, nem toboroz
A Study of Encorafenib Plus Cetuximab Taken Together With Pembrolizumab Compared to Pembrolizumab Alone in People With Previously Untreated Metastatic Colorectal Cancer
NCT05217446· 2. fázis· Pfizer· Forrás
Toboroz
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
NCT04831580· GOG Foundation· Forrás
Contact: Joslyn Walker
Fut, nem toboroz
A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer
NCT04607421· 3. fázis· Pfizer· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Hibát jelzek